Publication | Closed Access
Activity of a Novel bcl-2/bcl-xL-Bispecific Antisense Oligonucleotide Against Tumors of Diverse Histologic Origins
149
Citations
39
References
2001
Year
The bcl-2/bcl-xL-bispecific antisense oligonucleotide 4625 merits further study as a novel compound for cancer therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1